(MENAFN- GetNews) "PCSK9 Inhibitors Market"The PCSK9 Inhibitors market size reached ~USD 2 billion in 2023 in 7MM and is ...

Heart disease is the leading cause of death in the United States. But about 80 percent of cases are considered preventable.

One reason is that although the test is comparatively inexpensive — sometimes up to $300, but often $100 or less — patients ...

Coronary artery calcium exams help determine whether people can benefit from statins — and they are underused, some health ...

Coronary artery calcium tests can provide a more precise estimate of her risk of atherosclerotic heart disease.

Sanofi and Regeneron have scored a major victory in their fight with Amgen in the market for cardiovascular drugs, after releasing data showing their Praluent injection reduces risk of ...

Sanofi is reorganising its business units from seven to five in a bid to streamline its operations and ensure the success of its ambitious product launch plans.

In a report released today, Salim Syed from Mizuho Securities maintained a Hold rating on Amgen, with a price target of $280.00. The company’s shares closed last Friday at $296.47. Take advantage of ...

Heart disease: I’m a cardiologist. Here are 10 science-based ways to prevent it By Eric Topol, MD Washington Post· 29 Jul, 2025 03:32 AM9 mins to read Save ...

Repatha® (evolocumab) sales increased 31% year-over-year to $696 million in the second quarter, driven by 36% volume growth, partially offset by unfavorable changes to estimated sales deductions.

For those already on maximally tolerated statins and who have an LDL-C level ≥70 mg/dL, a nonstatin lipid-lowering agent such as ezetimibe, evolocumab, alirocumab, inclisiran or bempedoic acid is also ...